Baker Biotech Capital (Gp), Llc

Affiliations

  • Large Shareholder at Tranzyme Inc (TZYM), 2012-03-14
  • Large Shareholder, Director at Genomic Health Inc (GHDX), 2012-03-09
  • Large Shareholder at Xoma Corp (XOMA), 2012-03-09
  • Large Shareholder at Pharmacyclics Inc (PCYC), 2012-02-14
  • Large Shareholder, Director at Synageva Biopharma Corp (GEVA), 2012-01-10
  • Large Shareholder, Director at Seattle Genetics Inc (SGEN), 2012-01-05
  • Large Shareholder at Adolor Corp (ADLR), 2012-01-03
  • Large Shareholder at Viropharma Inc (VPHM), 2011-12-16
  • Large Shareholder at Auxilium Pharmaceuticals Inc (AUXL), 2011-08-03
  • Large Shareholder at Ap Pharma Inc (APPA), 2011-07-06
  • Large Shareholder, Director at Incyte Corp (INCY), 2010-09-23
  • Large Shareholder at Vaxgen Inc (VXGN.OB), 2010-07-29
  • Large Shareholder at Biocryst Pharmaceuticals Inc (BCRX), 2009-06-01
  • Large Shareholder at Allos Therapeutics Inc (ALTH), 2009-02-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TZYM $3.01 4,592 Large Shareholder 232,011 2012-03-14 Filing
TZYM $2.99 7,484 Large Shareholder 227,419 2012-03-14 Filing
TZYM $2.96 15,599 Large Shareholder 219,935 2012-03-13 Filing
TZYM $2.55 56,187 Large Shareholder 204,336 2012-03-12 Filing
TZYM $2.34 32,155 Large Shareholder 148,149 2012-03-12 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AUXL $17.25 6,361 Large Shareholder 844,839 2011-08-02 Filing
AUXL $18.04 61,519 Large Shareholder 851,200 2011-08-01 Filing
AUXL $18.03 40,690 Large Shareholder 912,719 2011-08-01 Filing
ADLR $1.18 376 Large Shareholder 79,054 2010-10-29 Filing
ADLR $1.19 885 Large Shareholder 79,430 2010-10-28 Filing